Patient#	Sample#	FRAP1:(FRAP1, protein),	HLX:(HLX, protein),	IFNG:(IFNG, protein),	IL1B:(IL1B, protein),	IL4:(IL4, protein),	MKK3-MKK6:(MKK3-MKK6, protein),	RIPK2:(RIPK2, protein),	SOCS1:(SOCS1, protein),	STAT1:(STAT1, protein),	STAT3:(STAT3, protein),	STAT4:(STAT4, protein),	STAT5A:(STAT5A, protein),	SPHK2:(SPHK2, protein),	ATF2	CCL3:(CCL3, protein),	CCL4:(CCL4, protein),	CCR5:(CCR5, protein),	EOMES:(EOMES, protein),	FASLG:(FASLG, protein),	FOS:(FOS, protein),	GADD45B:(GADD45B, protein),	GADD45G:(GADD45G, protein),	MKK3-MKK6-active:(GADD45B, active),(GADD45G, active),(MKK3-MKK6, active),(MKK3-MKK6-active, protein),	MAPK14:(MAPK14, protein),(MKK3-MKK6-active, active),	RAB7A:(RAB7A, protein),	lysosomal transport:(RAB7A, active),	GZMA:(GZMA, protein),	GZMB:(GZMB, protein),	IL12/IL12R/TYK2/JAK2	IL12/IL12R/TYK2/JAK2/SOCS1:(IL12/IL12R/TYK2/JAK2, active),(SOCS1, active),	IL12/IL12R/TYK2/JAK2/SPHK2:(IL12/IL12R/TYK2/JAK2, active),(SPHK2, active),	LCK:(IL12/IL12R/TYK2/JAK2, active),(LCK, protein),	NF kappa B2 p52/RelB:(IL12/IL12R/TYK2/JAK2, active),(regulation of dendritic cell antigen processing and presentation, active),	STAT1 (dimer):(CD8-positive alpha-beta T cell lineage commitment, active),(IFNG, active),(IL12/IL12R/TYK2/JAK2, active),(IL2/IL2R, active),(MAPK14, active),(STAT1, active),(T-helper 1 cell differentiation, active),	STAT5A (dimer):(IFNG, active),(IL12/IL12R/TYK2/JAK2, active),(STAT5A, active),(T-helper 1 cell differentiation, active),	STAT3 (dimer):(CD8-positive alpha-beta T cell lineage commitment, active),(FRAP1, active),(IL12/IL12R/TYK2/JAK2, active),(IL2/IL2R, active),(MAPK14, active),(STAT3, active),	STAT6:(IL12/IL12R/TYK2/JAK2, active),(STAT6, protein),(T-helper 1 cell lineage commitment, active),	natural killer cell mediated cytotoxicity:(IL12/IL12R/TYK2/JAK2/SOCS1, active),	IL1R1:(IL1R1, protein),	NOS2:(NOS2, protein),	STAT4 (dimer):(HLX, active),(IL12/IL12R/TYK2/JAK2, active),(IL12/IL12R/TYK2/JAK2/SPHK2, active),(IL18/IL18R, active),(MAPK14, active),(RIPK2, active),(STAT4, active),(natural killer cell activation, active),	TBX21:(TBX21, protein),	NF kappa B1 p50/RelA:(IL18/IL18R, active),(STAT4 (dimer), active),	T cell proliferation:(IL12/IL12R/TYK2/JAK2/SOCS1, active),(STAT4 (dimer), active),	proteasomal ubiquitin-dependent protein catabolic process:(STAT4 (dimer), active),	
